資源描述:
《益氣活血通脈合劑治療2型糖尿病周?chē)窠?jīng)病變的臨床研究》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。
1、提要目的:觀察益氣活血通脈合劑對(duì)2型糖尿病周?chē)窠?jīng)病變的療效。探討益氣活血通脈合劑治療2型糖尿病周?chē)窠?jīng)病變的機(jī)制,并為臨床治療提供理論及應(yīng)用價(jià)值。方法:入選符合試驗(yàn)標(biāo)準(zhǔn)的2型糖尿病周?chē)窠?jīng)病變患者60例,并隨機(jī)分為2組,其中治療組30例,對(duì)照組30例,均要求在血糖控制良好的基礎(chǔ)上,治療組給予益氣活血通脈合劑治療;對(duì)照組給予糖脈康顆粒治療。療效觀察時(shí)間為8周(共一個(gè)療程)。觀察患者治療前后的臨床癥狀,以及空腹血糖、餐后血糖、血脂、血流變、神經(jīng)傳導(dǎo)速度等指標(biāo)。結(jié)果:經(jīng)臨床觀察,治療組在本病的臨床癥狀改善方面,以及血糖、血脂等的指標(biāo)改善優(yōu)于對(duì)照組(P<0
2、.05);神經(jīng)傳導(dǎo)速度、血流變等方面的療效明顯優(yōu)于對(duì)照組(P<0.01);在治療過(guò)程中尚未發(fā)生不良反應(yīng)。結(jié)論:臨床觀察表明益氣活血通脈合劑治療2型糖尿病周?chē)窠?jīng)病變,可明顯改善患者的臨床癥狀,以及患者的血糖、血脂、神經(jīng)傳導(dǎo)速度、血流變等指標(biāo),在糾正患者血液的高凝狀態(tài),改善神經(jīng)傳導(dǎo)速度以及預(yù)防周?chē)窠?jīng)病變方面療效顯著,并且無(wú)明顯不良反應(yīng),是預(yù)防和治療糖尿病周?chē)窠?jīng)病變的有效方法,值得進(jìn)一步研究和推廣。關(guān)鍵詞2型糖尿?。恢?chē)窠?jīng)病變;益氣活血通脈合劑ClinicalStudyonTreatmentofPeripheralNeuropathyDisease
3、CausedbyType2DiabetesWithYiqihuoxuetongmaipulseMixtureSpeciality:InternalMedicineofTCMAuthor:ZhangguifenTutor:ProfessorZhaoquanlinAbstractObject:ToinvestigatetheeffectsofYiqihuoxuetongmaipulseMixtureonperipheralneuropathydiseaseintype2diabeticpatientsrelatedfactors.Toinvestigat
4、eYiqihuoxuetongmaipulsemixtureofperipheralneuropathyinthetreatmentofdiabetes,andthemechanismofclinicaltheoryvalueandprovideapplicationvalue.Methods:Inaccordwithteststandardsofperipheralneuropathyindiabetespatients60cases,andrandomlydividedintotwogroups,including30casesintreatme
5、ntgroupandcontrolgroupin30cases,Underthebasicpremiseofreducingthebloodplasmaglucose,30patientsweretreatedwithYiqihuoxuetongmaipulsemixtureintreatedgroup,othersweretreatedwithTangmaikangKeliincontrolgroup.Clinicalobservationontimeforeightweeks(aperiodoftreatment).Observepatients
6、beforeandaftertreatmentoftheclinicalsymptoms,andfastingandpostprandialbloodsugar,bloodfatandnerveconductionspeed,suchasitindex.Results:Theclinicalobservation,thetreatmentgroupintheclinicalsymptomsimprovedbetterthancontrolgroup(P<0.05);Bloodsugar,bloodfatandnerveconductionveloci
7、ty,theeffectofit,muchbetterthancontrolgroup(P<0.05);Andinthehealingprocesshasnotyetoccurredadversereactions.Conclusion:ClinicalobservationshowsthatYiqihuoxuetongmaipulsemixturethetreatmentoftype2diabeticperipheralneuropathy,cangreatlyimprovetheclinicalsymptoms,andthepatient'sbl
8、oodsugar,bloodfat,nerveconductionspeed,suchasitindex,i